Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 14, 2020

Total Value: $94.56M (96.9% shares, 3.1% debt)

Holdings (27)

LGND LIGAND PHARMACEUTICALS 12.4%

Value $11.7M Shares 160,919 Est. Cost $56.68 Unrealized 0.0%

— IVERIC BIO INC 9.4%

Value $8.888M Shares 2,583,786 Est. Cost $1.30 Unrealized —

— CTI BIOPHARMA CORP 6.3%

Value $5.916M Shares 6,430,637 Est. Cost $2.16 Unrealized —

— AMARIN CORP PLC -ADR 5.6%

Value $5.252M Shares 1,313,100 Est. Cost $9.14 Unrealized —

— AFFIMED NV 5.0%

Value $4.74M Shares 3,000,000 Est. Cost $2.75 Unrealized —

— CATALYST BIOSCIENCES INC 4.7%

Value $4.454M Shares 1,019,196 Est. Cost $5.11 Unrealized —

— STEMLINE THERAPEUTICS INC 4.5%

Value $4.291M Shares 886,632 Est. Cost $4.84 Unrealized —

XOMA XOMA CORP 4.5%

Value $4.245M Shares 208,600 Est. Cost $14.24 Unrealized +62.1%

— OPIANT PHARMACEUTICALS INC 3.9%

Value $3.649M Shares 380,948 Est. Cost $15.15 Unrealized —

— NEOS THERAPEUTICS INC 3.7%

Value $3.518M Shares 4,690,146 Est. Cost $1.80 Unrealized —

— OXFORD IMMUNOTEC GLOBAL PLC 3.7%

Value $3.467M Shares 374,431 Est. Cost $16.13 Unrealized —

EOLS EVOLUS INC 3.6%

Value $3.415M Shares 822,960 Est. Cost $11.17 Unrealized -24.2%

— ADAMAS PHARMACEUTICALS INC 3.6%

Value $3.361M Shares 1,162,876 Est. Cost $4.81 Unrealized —

CPIX CUMBERLAND PHARMACEUTICALS 3.5%

Value $3.295M Shares 907,735 Est. Cost $5.80 Unrealized -22.9%

— APOLLO ENDOSURGERY INC 3.4%

Value $3.233M Shares 1,683,861 Est. Cost $4.35 Unrealized —

— CIDARA THERAPEUTICS INC 3.4%

Value $3.231M Shares 1,302,981 Est. Cost $2.48 Unrealized —

— AEGERION PHARMACEUTICALSAEGR 5 04/01/25 3.1%

Value $2.886M Shares 3,037,627 Est. Cost $0.95 Unrealized —

— BIODELIVERY SCIENCES INTL 3.0%

Value $2.861M Shares 755,000 Est. Cost $3.79 Unrealized —

— CHIASMA INC 2.9%

Value $2.716M Shares 744,134 Est. Cost $3.97 Unrealized —

DMAC DIAMEDICA THERAPEUTICS INC 2.4%

Value $2.311M Shares 825,297 Est. Cost $4.13 Unrealized 0.0%

— SEASPINE HOLDINGS CORP 2.2%

Value $2.068M Shares 253,131 Est. Cost $8.17 Unrealized —

— APPLIED GENETIC TECHNOLOGIES 2.0%

Value $1.925M Shares 586,969 Est. Cost $3.28 Unrealized —

— BAUDAX BIO INC 1.6%

Value $1.513M Shares 610,200 Est. Cost $2.48 Unrealized —

IDXG INTERPACE BIOSCIENCES INC 1.0%

Value $924K Shares 178,295 Est. Cost $0.50 Unrealized —

— ANTARES PHARMA INC 0.4%

Value $357K Shares 151,189 Est. Cost $2.36 Unrealized —

— HTG MOLECULAR DIAGNOSTICS 0.3%

Value $323K Shares 992,641 Est. Cost $1.63 Unrealized —

— RIGEL PHARMACEUTICALS INC 0.0%

Value $16,000 Shares 10,000 Est. Cost $1.60 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
LGND	LIGAND PHARMACEUTICALS	160,919	$11.7M	12.4%	$56.68	0.0%	COM NEW	53220K504
—	IVERIC BIO INC	2,583,786	$8.888M	9.4%	$1.30	—	COM	46583P102
—	CTI BIOPHARMA CORP	6,430,637	$5.916M	6.3%	$2.16	—	COM	12648L601
—	AMARIN CORP PLC -ADR	1,313,100	$5.252M	5.6%	$9.14	—	SPONS ADR NEW	023111206
—	AFFIMED NV	3,000,000	$4.74M	5.0%	$2.75	—	COM	N01045108
—	CATALYST BIOSCIENCES INC	1,019,196	$4.454M	4.7%	$5.11	—	COM NEW	14888D208
—	STEMLINE THERAPEUTICS INC	886,632	$4.291M	4.5%	$4.84	—	COM	85858C107
XOMA	XOMA CORP	208,600	$4.245M	4.5%	$14.24	+62.1%	COM	98419J206
—	OPIANT PHARMACEUTICALS INC	380,948	$3.649M	3.9%	$15.15	—	COM	683750103
—	NEOS THERAPEUTICS INC	4,690,146	$3.518M	3.7%	$1.80	—	COM	64052L106
—	OXFORD IMMUNOTEC GLOBAL PLC	374,431	$3.467M	3.7%	$16.13	—	ORD SHS	G6855A103
EOLS	EVOLUS INC	822,960	$3.415M	3.6%	$11.17	-24.2%	COM	30052C107
—	ADAMAS PHARMACEUTICALS INC	1,162,876	$3.361M	3.6%	$4.81	—	COM	00548A106
CPIX	CUMBERLAND PHARMACEUTICALS	907,735	$3.295M	3.5%	$5.80	-22.9%	COM	230770109
—	APOLLO ENDOSURGERY INC	1,683,861	$3.233M	3.4%	$4.35	—	COM	03767D108
—	CIDARA THERAPEUTICS INC	1,302,981	$3.231M	3.4%	$2.48	—	COM	171757107
—	AEGERION PHARMACEUTICALSAEGR 5 04/01/25	3,037,627	$2.886M	3.1%	$0.95	—	NOTE 5.000% 4/0	00767EAC6
—	BIODELIVERY SCIENCES INTL	755,000	$2.861M	3.0%	$3.79	—	COM	09060J106
—	CHIASMA INC	744,134	$2.716M	2.9%	$3.97	—	COM	16706W102
DMAC	DIAMEDICA THERAPEUTICS INC	825,297	$2.311M	2.4%	$4.13	0.0%	COM NEW	25253X207
—	SEASPINE HOLDINGS CORP	253,131	$2.068M	2.2%	$8.17	—	COM	81255T108
—	APPLIED GENETIC TECHNOLOGIES	586,969	$1.925M	2.0%	$3.28	—	COM	03820J100
—	BAUDAX BIO INC	610,200	$1.513M	1.6%	$2.48	—	COM	07160F107
IDXG	INTERPACE BIOSCIENCES INC	178,295	$924K	1.0%	$0.50	—	COM	46062X303
—	ANTARES PHARMA INC	151,189	$357K	0.4%	$2.36	—	COM	036642106
—	HTG MOLECULAR DIAGNOSTICS	992,641	$323K	0.3%	$1.63	—	COM	40434H104
—	RIGEL PHARMACEUTICALS INC	10,000	$16,000	0.0%	$1.60	—	COM NEW	766559603